U.S. AGENT · SERVICE DETAILS

Agent information changes and maintenance

Review changes to contact details and ongoing maintenance for an existing service record.

Applicability and scope depend on the product, your business role and the agreed engagement. The service does not constitute FDA approval or certification.

SERVICE OVERVIEW

What does this service help with?

For existing service records, changes in communication mode and follow-up contact information maintenance, we will first identify specific matters to be addressed and the scope of collaboration, taking into account product categories and the applicability of current information.

WHO MAY NEED IT

Who should consider this service?

Enterprises with offshore facilities or manufacturers ' U.S. agent arrangements need to be identified according to the respective FDA product area, whether they need to be processed or whether they need to be identified on a case-by-case basis in relation to the type of product, the activity of the enterprise, the target market and the applicable legislation.

SCOPE & APPROACH

What we typically discuss

Identify information gaps before agreeing on documentation and responsibilities.

01

Confirm the product and business entity

Review product characteristics, responsible businesses and facilities, activities and existing records to select the appropriate process.

02

Review applicable requirements

Confirm requirements and open questions about registration, listing, documentation, labels or contact information relevant to the service.

03

Agree on the specific scope

Discuss required documents, responsibilities, timing and fees. The agreed scope governs the work.

GET READY

What to prepare before contacting us

If documents are incomplete, share the product and current stage first. You can provide the remaining details later.

  • Product regulatory area and offshore facility/manufacturer information
  • Legal name, address and FDA records available
  • Existing U.S. focal point for information and development
HOW TO START

From initial review to engagement

STEP 01

Describe your current needs

Share the product, your role, target market and current stage.

STEP 02

Provide additional materials

Prepare relevant facility, product, technical or label records based on the service.

STEP 03

Confirm service arrangements

Define the applicable requirements, scope, documentation responsibilities and fees.

STEP 04

Proceed with the agreed work

Work within the confirmed scope and discuss applicable maintenance.

Registration, listing or submission of supporting information does not confer FDA approval, certification or marketing authorization. Refer to current FDA requirements and the facts of your project.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FDA rules checked November 5, 2026. Verify charges for the applicable date or fiscal year.

Timing and preparation

Document preparation

The facilities, existing agents, registration status, authorization and effective contact details are checked first to arrange for designation or replacement and contact handover.

FDA processing

(a) The appointment, replacement and maintenance time is affected by the account, the original record, the consent of the agent and the integrity of the information; Daily contact is agreed on a service agreement and there is no commitment to resolve all FDA issues within a fixed number of days.

Fee breakdown

FDA fees

U.S. agent service fees are agreed between the parties and are not user fees charged by the FDA for agent services; The registration, application or other application of the FDA for the facility on whose behalf the facility is represented is separately charged.

Service fees

Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.

Other possible costs

Testing, translation, software and other third-party work are quoted separately where needed.

START WITH YOUR PRODUCT

Tell us about your product so we can discuss the appropriate pathway.

Share intended use, ingredients or technical characteristics, production location, business role and current stage. We can use this information to discuss likely FDA requirements and service scope.